Insilico Biotechnology
Engineering Software · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Meitnerstraße 9, Stuttgart, Baden-Wuertt...Phone Number
+49 7114605940Revenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Insilico Biotechnology
Insilico provides digital twin technology for process development and drug manufacturing, selected by six of the top ten biopharma companies. Their solutions enhance productivity and product quality through virtual experimentation. Insilico aims to transform companies into smart biofactories by leveraging predictive modeling in the Biopharma sector. They focus on providing innovative tools and methodologies to improve efficiency in drug development.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insilico Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Insilico Biotechnology has new funding data
Insilico Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Insilico Biotechnology launches new products
Website visits: Recent activity has been detected on your website
Check if Insilico Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Insilico Biotechnology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Insilico Biotechnology
Check out if Insilico Biotechnology is spiking on competitors!
Earning: See what the market has to say on Insilico Biotechnology recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Insilico Biotechnology as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Insilico Biotechnology is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Insilico Biotechnology is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Insilico Biotechnology.
Insilico Biotechnology Tech Stack
A closer look at the technologies used by Insilico Biotechnology
See more technologies
Insilico Biotechnology News & Media
横河電機 革新的なバイオプロセス向けデジタルツイン技術をもつInsilico Biotechnologyを買収
東京--(BUSINESS WIRE)--（ビジネスワイヤ） -- 横河電機株式会社（本社：東京都武蔵野市 代表取締役社長：奈良 寿）は、バイオプロセス分野向けにソフトウェアの開発、およびサービスを提供しているInsilico Biotechnology AG（インシリコ バイオテクノロジー AG 本社：ドイツ シュトゥットガルト CEO：Klaus Mauch 以下 Insilico社）の株式を100％取得いたしましたので、お知らせします。当社はサステナビリティ目標において、バイオエコノミー確立への貢献を重点課題の一つとしていますが、その基盤分野であるバイオプロセスをバイオ医薬品向けに展開し、開発から生産までのトータルソリューションの構築を目指します。 新型コロナウイルス感染症（COVID-19）のパンデミックという背景もあり、副作用が少なく、難治性が高い疾患や希少な疾患にも適用できると言われるバイオ医薬品は、需要がますます高まっています。しかし、化学合成による一般的な医薬品と比べてトータルコストが高く、ターゲットとするたんぱく質を安定的に効率良く得るための細胞培養工程は複雑で、厳Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
TOKYO--(BUSINESS WIRE)-- #Bioprocess--Yokogawa Electric Corp. has acquired all shares of Insilico Biotechnology AG, a German developer and provider of bioprocess software and services.
Read more news
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insilico Biotechnology
Sign Up For FreeTo access detailed company insights
Insilico provides digital twin technology for process development and drug manufacturing, selected by six of the top ten biopharma companies. Their solutions enhance productivity and product quality through virtual experimentation. Insilico aims to transform companies into smart biofactories by leveraging predictive modeling in the Biopharma sector... Read More
